Lactose (India)

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058I01013
  • NSEID:
  • BSEID: 524202
INR
84.98
-1.13 (-1.31%)
BSENSE

Mar 23

BSE+NSE Vol: 5.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.20% vs 73.09% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -10.80% vs 67.08% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.18% vs -11.69% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -23.95% vs 461.77% in Mar 2024

Compare Profit and Loss Results of Lactose (India)
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
116.00
2.00
114.00
5,700.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
116.00
2.00
114.00
5,700.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-8.00
-9.00
1.00
11.11%
Raw Materials Consumed
60.00
11.00
49.00
445.45%
Power & Fuel Cost
10.00
0.00
10.00
0%
Employee Cost
12.00
3.00
9.00
300.00%
Operating Expenses
14.00
0.00
14.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
0.00
4.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
2.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
99.00
9.00
90.00
1,000.00%
Operating Profit (PBDIT) excl Other Income
16.00
-7.00
23.00
328.57%
Other Income
1.00
1.00
0.00
0.00%
Operating Profit (PBDIT)
18.00
-6.00
24.00
400.00%
Interest
6.00
2.00
4.00
200.00%
Profit before Depriciation and Tax
12.00
-8.00
20.00
250.00%
Depreciation
5.00
0.00
5.00
0%
Profit Before Taxation & Exceptional Items
6.00
-8.00
14.00
175.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-8.00
14.00
175.00%
Provision for Tax
1.00
-1.00
2.00
200.00%
Profit After Tax
5.00
-7.00
12.00
171.43%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
-14.00
34.00
242.86%
Profit Available for appropriations
25.00
-22.00
47.00
213.64%
Appropriations
25.00
-22.00
47.00
213.64%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.1
-2.06
6.16
299.03%
Profit And Loss - Net Sales
Net Sales 116.40 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.20% vs 73.09% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -10.80% vs 67.08% in Mar 2024

Profit And Loss - Interest
Interest 6.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.18% vs -11.69% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 5.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -23.95% vs 461.77% in Mar 2024